What are Vocabria and Rekambys?
Vocabria and Rekambys are brand names for medicines used to treat HIV. They are typically used together as part of an HIV treatment regimen that does not rely on daily oral dosing for the same medicines once started. [1]
How are they used together (and what’s the dosing pattern)?
In practice, Vocabria (cabotegravir) is used first, then Rekambys (rilpivirine) is used with injections given on a schedule after the initial period. This approach is designed to establish that the patient can tolerate the medicines before switching to the ongoing injection dosing. [1]
What’s the difference between Vocabria and Rekambys?
Vocabria and Rekambys are different HIV drugs, used in combination:
- Vocabria contains cabotegravir.
- Rekambys contains rilpivirine. [1]
Who are these medicines for?
They’re used for people living with HIV who need an HIV regimen that can be delivered as long-acting injections (with the specific suitability depending on treatment history and viral factors). [1]
What side effects do people ask about?
Common concerns with long-acting injectable HIV regimens typically include injection-site reactions and side effects related to each medicine. The exact side effects to watch for depend on the patient and the product labeling. [1]
How does this compare with daily HIV pills?
Vocabria and Rekambys are used to achieve longer-lasting drug levels via injections, which can be an alternative to daily oral antiretroviral therapy for appropriate patients. [1]
Sources
- https://www.ema.europa.eu/en/medicines/human/EPAR/vocabria and https://www.ema.europa.eu/en/medicines/human/EPAR/rekambys